MedPath

Persistent Weight Loss with a Non-invasive Novel Medical Device In Obese Individuals With High-risk Cardiovascular Risk Profile

Not Applicable
Conditions
E66.9
Obesity, unspecified
Registration Number
DRKS00011357
Lead Sponsor
Praxis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
6
Inclusion Criteria

1. Age: 18 to 95 years
2. Gender: male + female
3. Capacity to consent
4. Signed consent form
5. Failure of a basic program (nutritional, exercise and behavioural therapy)
6. Received medical device
7. at least 2 documented visits after receiving the medical device

Exclusion Criteria

1. Weight reduction > 5% over the last months before inclusion into the study
2. Wasting disease
3. Medication influeincing weight loss
4. Pregnancy or breastfeeding women
5. Mental disorders or non-compliance
6. Incapacity to give informed consent
7. Participation in another therapy program or study
8. Exclsuion by dentist for dental of maxillary joint problems

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PEP is efficiency (weight reduction) of the medical device.
Secondary Outcome Measures
NameTimeMethod
The security of the medical device will be controlled through regular visits and participants have been advised to present immediately if problems occur. Anthropometric measurements will be done and they will be asked to complete two questionnaires during usage of the medical device. Furthermore participants will be followed up through telephone contacts. Detailed informations about the medical device will be given in a separate information brochure.<br>The mode of action will be assessed through questionnaires at the beginning and end of usage of the medical device.
© Copyright 2025. All Rights Reserved by MedPath